NASDAQ: AXSM
Axsome Therapeutics Inc Stock Ownership - Who owns Axsome Therapeutics?

Insider buying vs selling

Have Axsome Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Herriot TabuteauChief Executive Officer2025-11-0521,775$8.02
$174.64kBuy
Herriot TabuteauChief Executive Officer2025-11-0521,775$134.49
$2.93MSell
Herriot TabuteauChief Executive Officer2025-11-0450,459$8.02
$404.68kBuy
Herriot TabuteauChief Executive Officer2025-11-0450,459$133.79
$6.75MSell
Herriot TabuteauChief Executive Officer2025-11-0391,705$8.02
$735.47kBuy
Herriot TabuteauChief Executive Officer2025-11-0391,705$132.34
$12.14MSell
Herriot TabuteauChief Executive Officer2025-10-0812,774$118.84
$1.52MSell
Herriot TabuteauChief Executive Officer2025-10-0812,774$8.02
$102.45kBuy
Herriot TabuteauChief Executive Officer2025-10-0713,390$118.77
$1.59MSell
Herriot TabuteauChief Executive Officer2025-10-0713,390$8.02
$107.39kBuy

1 of 6

AXSM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AXSM insiders and whales buy or sell their stock.

AXSM Shareholders

What type of owners hold Axsome Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Herriot Tabuteau29.15%14,696,229$2.22BInsider
Antecip Capital LLC14.57%7,344,500$1.11BInsider
Vanguard Group Inc8.29%4,180,646$632.11MInstitution
Blackrock Inc7.52%3,790,929$573.19MInstitution
Wellington Management Group LLP2.65%1,334,560$201.79MInstitution
Rtw Investments LP2.22%1,118,883$169.18MInstitution
Macquarie Group Ltd2.15%1,084,536$163.98MInstitution
Price T Rowe Associates Inc2.06%1,037,448$156.86MInstitution
Geode Capital Management LLC1.98%997,700$150.85MInstitution
Invesco Ltd1.96%990,557$149.77MInstitution

1 of 3

AXSM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AXSM61.67%38.33%Net SellingNet Selling
MRUS89.99%10.01%Net Buying
RYTM98.14%1.86%Net SellingNet Buying
NUVL75.84%24.16%Net SellingNet Selling
ABVX81.93%0.00%

Axsome Therapeutics Stock Ownership FAQ

Who owns Axsome Therapeutics?

Axsome Therapeutics (NASDAQ: AXSM) is owned by 73.62% institutional shareholders, 45.75% Axsome Therapeutics insiders, and 0.00% retail investors. Herriot Tabuteau is the largest individual Axsome Therapeutics shareholder, owning 14.70M shares representing 29.15% of the company. Herriot Tabuteau's Axsome Therapeutics shares are currently valued at $2.21B.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.